Data from Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression

Liang Shi(302 Military Hospital of China), Chawnshang Chang(China Medical University), Renan Jin, Shuyuan Yeh(University of Rochester Medical Center), Wen‐Lung Ma(Asia University), Junjie Xu(National Instruments (Ireland)), Hui Lin(Northwestern University), Xiujun Cai(National Instruments (Ireland)), Yin Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Gonghui Li(Sir Run Run Shaw Hospital)
Unknown
April 3, 2023
10.1158/1535-7163.c.6539124.v1
Cited by 0

Related Papers

A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging
|Science|2015|542
Induction of the TRPM-2 gene in cells undergoing programmed death.
|Molecular and Cellular Biology|1989|463
Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
|Gastroenterology|2008|253
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
|Nature Communications|2019|223
Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma
|Cell Death and Disease|2017|220